​

IMPACT OF CERVICOVAGINAL MICROBIOME ON THE RISK OF CERVICAL ABNORMALITIES DEVELOPMENT. Rosário A, Sousa A, Varandas T, Marinho-Dias J, Medeiros R, Martins G, Monteiro P, Sousa H. J Med Virol. 2023 May;95(5):e28762. (IF=20.693) https://doi.org/10.1002/jmv.28762

 

 

NEW APPROACHES IN EARLY-STAGE NSCL MANAGEMENT: POTENTIAL USE OF PARP INHIBITORS AND IMMUNOTHERAPY COMBINATION. Pina M, Oliveira C, Sousa H, Oliveira J. Int J Mol Sci 2023 Feb 17;24(4):4044. (IF=6.208) https://doi.org/10.3390/ijms24044044.

 

IMPACT OF HIGH-RISK HUMAN PAPILLOMAVIRUS GENOTYPING IN CERVICAL DISEASE IN THE NORTHERN REGION OF PORTUGAL: REAL-WORLD DATA FROM REGIONAL CERVICAL CANCER SCREENING PROGRAM. Rosário A, Sousa A, Marinho-Dias J, Medeiros R, Lobo C, Leça L, Coimbra N, Tavares F, Baldaque I, Martins G, Monteiro P, Henrique R, Sousa H. J Med Virol. 2023 Jan;95(1):e28414. (IF=20.693) https://doi.org/10.1002/jmv.28414

 

MICRORNAS AS POTENTIAL TOOLS FOR PREDICTING CANCER PATIENTS’ SUSCEPTIBILITY TO SARS-COV-2 INFECTION AND VACCINATION RESPONSE. Dias TR, Dias, F, Teixeira AL, Sousa H, Oliveira J, Medeiros R. Cells 2022, 11(15), 2279; (IF=7.666) https://doi.org/10.3390/cells11152279

 

SARS-COV-2 INTRODUCTIONS AND EARLY DYNAMICS OF THE EPIDEMIC IN PORTUGAL. Borges V, Isidro J, Trovão NS, Duarte S, Cortes-Martins H, Martiniano H, Gordo I, Leite R, Vieira L, Portuguese network for SARS-CoV-2 genomics(Consortium), Guiomar R, Gomes JP. Communications Medicine 2022, 2:10; (IF: NA) https://doi.org/10.1038/s43856-022-00072-0

 

PD-L1 EXPRESSION IN EBV ASSOCIATED GASTRIC CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS.Lima A, Sousa H, Medeiros R, Nobre A, Machado M. Discover Oncology, 2022,13(1),19; (IF=4.667)https://doi.org/10.1007/s12672-022-00479-0

 

OMNISARS2: A HIGHLY SENSITIVE AND SPECIFIC RT-QPCR-BASED COVID-19 DIAGNOSTIC METHOD DESIGNED TO WITHSTAND SARS-COV-2 LINEAGE EVOLUTION. Carvalho-Correia E, Calçada C, Branca F, Posada D, Sousa H, Sousa J, Veiga MI, Osório NS. Biomedicines 2021, 9(10), 1314; (IF=6.081) https://doi.org/10.3390/biomedicines9101314.

 

THE IMPACT OF COVID-19 PANDEMIC IN PORTUGUESE CANCER PATIENTS: A RETROSPECTIVE STUDY. Lima A, Sousa H, Nobre A, Faria AL, Machado M. Int J Environ Res Public Health (2021) 18: 8552. (IF=3.390)https://doi.org/10.3390/ijerph18168552.

 

PERFORMANCE OF DNA METHYLATION-BASED BIOMARKERS IN THE CERVICAL CANCER SCREENING PROGRAM OF NORTHERN PORTUGAL: A FEASIBILITY STUDY. Salta S, Maia-Moço L, Estevão-Pereira H, Sequeira JP, Vieira R, Bartosch C, Petronilho S, Monteiro P, Sousa A, Baldaque I, Rodrigues J, Sousa H, Tavares F, Henrique R, Jerónimo C. Int J Cancer. 2021 Dec 1;149(11):1916-1925. (IF=5.145) https://doi.org/10.1002/ijc.33778.

 

OPTIMIZATION AND CLINICAL EVALUATION OF A MULTI-TARGET LOOP-MEDIATED ISOTHERMAL AMPLIFICATION ASSAY FOR THE DETECTION OF SARS-COV-2 IN NASOPHARYNGEAL SAMPLES. Roumani F, Azinheiro S, Sousa H, Tavares A, Timóteo M, Varandas T, Fonseca-Silva D, Baldaque I, Carvalho J, Prado M, Garrido-Maestu A. Viruses. 2021 May 19;13(5):940. (IF=3.816) https://doi.org/10.3390/v13050940.

 

ASSOCIATION OF MURINE DOUBLE MINUTE 2 POLYMORPHISMS ASSOCIATION WITH GASTRIC CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS. Timóteo M, Tavares, A, Cruz S, Campos C, Medeiros R, Sousa H. Biomed Rep. 2021 Aug;15(2):69. (IF=NA) https://doi.org/10.3892/br.2021.1445.

 

FUNCTIONAL GENETIC VARIANTS IN ATG10 ARE ASSOCIATED WITH ACUTE MYELOID LEUKEMIA. Castro I, Sampaio-Marques B, Areias AC, Sousa H, Fernandes A, Sanchez-Maldonado JM, Cunha S, Carvalho A, Sainz J and Ludovico P. Cancers (Basel). 2021 Mar 16;13(6):1344. (IF=6.126) https://doi.org/10.3390/cancers13061344.

 

THE EARLY DYNAMICS OF THE SARS-COV-2 EPIDEMIC IN PORTUGAL. Borges V, Isidro J, Trovão NS, Duarte S, Cortes-Martins H, Martiniano H, Gordo I, Leite R, Vieira L, Portuguese network for SARS-CoV-2 genomics (Consortium), Guiomar R, Gomes JP. medRxiv 2021.02.22.21252216; https://doi.org/10.1101/2021.02.22.21252216

 

MASSIVE DISSEMINATION OF A SARS-COV-2 SPIKE Y839 VARIANT IN PORTUGAL. Borges V, Isidro J, Cortes-Martins H, Duarte S, Vieira L, Leite R, Gordo I, Caetano CP, Nunes B, Sá R, Oliveira A, Guiomar R; Portuguese network for SARS-CoV-2 genomics, Gomes JP. Emerg Microbes Infect. 2020 Dec;9(1):2488-2496. (IF=5.776)https://doi.org/10.1080/22221751.2020.1844552.

 

RECOMMENDATIONS FOR THE INTRODUCTION OF METAGENOMIC NEXT-GENERATION SEQUENCING IN CLINICAL VIROLOGY, PART I: WET LAB PROCEDURE. López-Labrador FX, Brown JR, Fischer N, Harvala H, Van Boheemen S, Cinek O, Sayiner A, Madsen TV, Auvinen E, Kufner V, Huber M, Rodriguez C, Jonges M, Hönemann M, Susi P, Sousa H, et al. J Clin Virol. 2020 Nov 18;134:104691. (IF=2.777) https://doi.org/10.1016/j.jcv.2020.104691.

 

THE PREVALENCE AND RISK-FACTORS OF ORAL HPV DNA DETECTION AMONG HIV-INFECTED MEN BETWEEN MEN WHO HAVE SEX WITH MEN AND HETEROSEXUAL MEN. Gonçalves H, Silva J, Maury IP, Tavares A, Campos C, Sousa H, Jacinto A, Aguir P, Caldeira L, Medeiros R. Infect Dis (Lond). 2020 Sep 11:1-12. (IF=2.494)https://doi.org/10.1080/23744235.2020.1811373.

 

HUMAN PAPILLOMAVIRUS PREVALENCE AND DISTRIBUTION IN SELF-COLLECTED SAMPLES FROM FEMALE UNIVERSITY STUDENTS IN MAPUTO. Bule Y, Silva J, Carrilho C, Campos C, Sousa H, Tavares A, Medeiros R. Int J Gynaecol Obstet. 2020 May;149(2):237-246. (IF=1.671) https://doi.org/10.1002/ijgo.13126.

 

EPSTEIN-BARR VIRUS IS ABSENT IN GASTRIC SUPERFICIAL NEOPLASTIC LESIONS. Ribeiro J, Malta M, Galaghar A, Afonso LP, Libânio D, Medeiros R, Dinis-Ribeiro M, Sousa H. Virchows Arch. 2019 Dec;475(6):757-762. (IF=2.868)https://doi.org/10.1007/s00428-019-02670-1.

 

HEPATITIS E VIRUS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: A SYSTEMATIC REVIEW. Cruz S, Campos C, Timóteo M, Tavares A, São José Nascimento M, Medeiros R, Sousa H. J Clin Virol. 2019 Oct;119:31-36. (IF=3.020) https://doi.org/10.1016/j.jcv.2019.08.002.

 

HIGH-RISK HUMAN PAPILLOMAVIRUS GENOTYPE DISTRIBUTION IN THE NORTHERN REGION OF PORTUGAL: DATA FROM REGIONAL CERVICAL CANCER SCREENING PROGRAM.  Sousa H, Tavares A, Campos C, Marinho-Dias J, Brito M, Medeiros R, Baldaque I, Lobo C, Leça L, Monteiro P, Tavares F, Henrique R. Papillomavirus Research. 2019 Dec;8:100179. Epub 2019 Aug 1. (IF=NA) https://doi.org/10.1016/j.pvr.2019.100179.

 

ASSOCIATION OF EPSTEIN-BARR VIRUS INFECTION ASSOCIATION WITH ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTED PATIENTS IN PORTUGAL. Marinho-Dias J, Baldaque I, Pinho-VAz C, Leite L, Branca R, Campilho F, Campos Jr A, Medeiros R, Sousa H. Mol Med Rep. 2019 Mar;19(3):1435-1442. (IF=1.851)https://doi.org/10.3892/mmr.2018.9794.

 

POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS: A SINGLE CENTER RETROSPECTIVE STUDY BETWEEN 2005 AND 2012. Marinho-Dias J, Lobo J, Henrique R, Baldaque I, (…) Sousa H. Mol Med Rep. 2018 Nov;18(5):4650-4656. (IF=1.851)https://doi.org/10.3892/mmr.2018.9433.

 

CURCUMIN AND RUTIN DOWN-REGULATE CYCLOOXYGENASE-2 AND REDUCE TUMOR-ASSOCIATED INFLAMMATION IN HPV16-TRANSGENIC MICE. Moutinho MSS, Aragão S, Carmo D, Casaca F, Silva S, Ribeiro J, Sousa H, et al. Anticancer Res. 2018 Mar;38(3):1461-1466. DOI: 10.21873/ANTICANRES.12371 (IF=1.935)

 

EXPRESSION PROFILE OF MICRORNA-146A ALONG HPV-INDUCED MULTISTEP CARCINOGENESIS - A STUDY IN HPV16 TRANSGENIC MICE. Araujo R, Santos JMO, Fernandes M, Dias F, Sousa H, et al. J Cancer Res Clin Oncol. 2018 Feb;144(2):241-248. (IF=3.332) https://doi.org/10.1007/s00432-017-2549-5.

 

CLINICAL AND PATHOLOGICAL CHARACTERIZATION OF EPSTEIN-BARR VIRUS ASSOCIATED GASTRIC CARCINOMAS IN PORTUGAL. Ribeiro J, Oliveira A, Malta M, Oliveira C, Silva F, Galaghar A, Afonso LP, Cassiano-neves M, Medeiros R, Pimentel-nunes P, Sousa H. World J Gastroenterol. Oct 28, 2017; 23(40): 7292-7302 (IF=3.300)https://doi.org/10.3748/wjg.v23.i40.7292

 

P53 DEREGULATION IN EPSTEIN-BARR VIRUS-ASSOCIATED GASTRIC CARCINOMAS. Ribeiro J, Malta M, Galaghar A, Silva F, Afonso LP, Medeiros R, Sousa H. Cancer Lett. 2017 Sep 28;404:37-43. (IF=6.491)https://doi.org/10.1016/j.canlet.2017.07.010.

 

REGULATION OF MIRNA-146A AND MIRNA-150 LEVELS BY CELECOXIB IN PRE-MALIGNANT LESIONS OF K14HPV16 MICE. da Costa RMG, Araujo R, Santos JOM, Fernandes M, Neto T, Sousa H, et al. Anticancer Res. 2017 Jun;37(6):2913-18. (IF=1.865) https://doi.org/10.21873/ANTICANRES.11644

 

DYSREGULATED EXPRESSION OF MICRORNA-150 IN HUMAN PAPILLOMAVIRUS-INDUCED LESIONS OF K14-HPV16 TRANSGENIC MICE. Santos JM, Fernandes M, Araújo R, Sousa H, et al. Life Sci. 2017 Mar 13. pii: S0024-3205(17)30091-7. (IF=3.230) https://doi.org/10.1016/j.lfs.2017.03.008.

 

EPSTEIN-BARR VIRUS GENE EXPRESSION AND LATENCY PATTERN IN GASTRIC CARCINOMAS: A SYSTEMATIC REVIEW. Ribeiro J, Oliveira C, Malta M, Sousa H. Future Oncol. 2017 Mar;13(6):567-579. (IF=2.360)https://doi.org/10.2217/fon-2016-0475.

 

HPV16 INDUCES A WASTING SYNDROME IN TRANSGENIC MICE: AMELIORATION BY DIETARY POLYPHENOLS VIA NF-KB INHIBITION. Gil da Costa RM, Aragão S, Moutinho M, Alvarado A, Carmo D, Casaca F, Silva S, Ribeiro J, Sousa H, et al. Life Sci. 2017 Jan 15;169:11-19. (IF=3.230) https://doi.org/10.1016/j.lfs.2016.10.031.

 

GENOTYPIC RESISTANCE OF CYTOMEGALOVIRUS TO ANTIVIRALS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS FROM PORTUGAL: A RETROSPECTIVE STUDY. Campos AB, Ribeiro J, Pinho-Vaz C, Campilho C, Branca R, Campos Jr A, Baldaque I, Medeiros R, Bouttoleau D, Sousa H. Antiviral Res. 2017 Feb;138:86-92. (IF=4.307) https://doi.org/10.1016/j.antiviral.2016.10.016.

 

EPSTEIN-BARR VIRUS STRAINS AND VARIATIONS: GEOGRAPHIC OR DISEASE-SPECIFIC VARIANTS? Neves M, MarinhoDias J, Ribeiro J, Sousa H. J Med Virol. 2017 Mar;89(3):373-387. (IF=1.988) https://doi.org/10.1002/jmv.24633.

 

GENETIC POLYMORPHISM IN DNMTs AND GASTRIC CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS. Neves M, Ribeiro J, Medeiros R, Sousa H. Porto Biomed J. 2016 Nov-Dec;1(5):164-172. (IF=NA)https://doi.org/10.1016/j.pbj.2016.10.005

 

PTAQUILOSIDE FROM BRACKEN (PTERIDIUM SPP.) INHIBITS TUMOUR-INFILTRATING CD8+ T CELLS IN HPV-16 TRANSGENIC MICE. Santos C, Ferreirinha P, Sousa H, Ribeiro J, Bastos M, Neto T, Oliveira P, Medeiros R, Vilanova M, Gil da Costa R. Food Chem Toxicol. 2016 Nov;97:277-285. (IF=3.778) https://doi.org/10.1016/j.fct.2016.09.019.

 

INFLUENCE OF GENETIC POLYMORPHISMS IN PROSTAGLANDIN E2 PATHWAY (COX-2/HPGD/SLCO2A1/ABCC4) ON THE RISK FOR COLORECTAL ADENOMA DEVELOPMENT AND RECURRENCE AFTER POLYPECTOMY. Pereira C, Queirós S, Galaghar A, Sousa H, et al. Clin Transl Gastroenterol. 2016 Sep 15;7(9):e191. (IF=3.923)https://doi.org/10.1038/ctg.2016.47.

 

CELECOXIB PROMOTES THE FUNCTION OF CD8+ T CELLS IN HPV-INDUCED LESIONS IN TRANSGENIC MICE. Santos C, Neto T, Ferreirinha P, Sousa H, Ribeiro J, Bastos M, Oliveira P, Medeiros R, Vilanova M, Gil da Costa R. Life Sci. 2016 May 31. pii: S0024-3205(16)30339-3. (IF=2.936) https://doi.org/10.1016/j.lfs.2016.05.040.

 

HUMAN CYTOMEGALOVIRUS ANTIVIRAL DRUGRESISTANCE MUTATIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION: CURRENT STATE OF THE ART. Campos AB, Ribeiro J, Boutolleau D, Sousa H. Rev Med Virol. 2016 May;26(3):161-82. (IF=5.439) https://doi.org/10.1002/rmv.1873.

 

5’UTR +24TC CR2 POLYMORPHISM IS NOT ASSOCIATED WITH RISK OF NASOPHARYNGEAL CARCINOMA DEVELOPMENT IN PORTUGAL. Sousa H, Bastos MJ, Ribeiro J, Oliveira S, Breda E, Catarino R, Medeiros R. Oral Dis. 2016 May;22(4):280-4. (IF=2.011) https://doi.org/10.1111/odi.12436.

 

POLYMORPHISMS IN HOST IMMUNE RESPONSE ASSOCIATED GENES AND RISK OF NASOPHARYNGEAL CARCINOMA DEVELOPMENT IN PORTUGAL. Sousa H, Mesquita L, Ribeiro J, Catarino R, Breda E, Medeiros R. Immunobiology 2016 Feb;221(2):145-52. https://doi.org/10.1016/j.imbio.2015.09.015

 

PREVALENCE OF ADENOVIRUS AND ROTAVIRUS INFECTION IN IMMUNOCOMPROMISED PATIENTS WITH ACUTE GASTROENTERITIS IN PORTUGAL. Ribeiro J, Ferreira D, Arrabalde C, Almeida S, Baldaque I, Sousa H. World J Virol. 2015 Nov 12;4(4):372-6. https://doi.org/10.5501/wjv.v4.i4.372.

 

miR-34a AND miR-125b EXPRESSION IN HPV INFECTION AND CERVICAL CANCER DEVELOPMENT. Ribeiro J, Marinho-Dias J, Monteiro P, Loureiro J, Baldaque I, Medeiros R, Sousa H. Biomed Res Int. 2015:304584. https://doi.org/10.1155/2015/304584.

 

LET-7C IS A CANDIDATE BIOMARKER FOR CERVICAL INTRAEPITHELIAL LESIONS: A PILOT STUDY. Malta M, Ribeiro J, Monteiro P, Loureiro J, Medeiros R, Sousa H. Mol Diagn Ther. 2015 Jun;19(3):191-6. https://doi.org/10.1007/s40291-015-0145-4.

 

CHARACTERIZATION OF EPSTEIN-BARR VIRUS STRAINS AND LMP1-DELETION VARIANTS IN PORTUGAL. Neves M, Marinho-Dias J, Ribeiro J, Esteves M, Maltez E, Baldaque I, Breda E, Monteiro E, Medeiros R, Sousa H. J Med Virol. 2015 Aug;87(8):1382-8. https://doi.org/10.1002/jmv.24190.

 

MICRORNA-21 EXPRESSION AND SUSCEPTIBILITY TO HPV-INDUCED CARCINOGENESIS - ROLE OF MICROENVIRONMENT IN K14-HPV16 MICE MODEL. Paiva I, Gil da Costa RM, Ribeiro J, Sousa H, Bastos M, Rocha AF, Lopes C, Oliveira PA, Medeiros R. Life Sci. 2015 May 1;128:8-14. https://doi.org/10.1016/j.lfs.2015.02.020.

 

FUTURE PERSPECTIVES OF SMARTPHONE APPLICATIONS FOR RHEUMATIC DISEASES SELF-MANAGEMENT. Azevedo R, Sousa H, Monteiro J, Lima R. Rheumatol Int. 2015 Mar;35(3):419-31. https://doi.org/10.1007/s00296-014-3117-9.

 

A ROLE FOR MICRORNA-155 EXPRESSION IN MICROENVIRONMENT ASSOCIATED TO HPV-INDUCED CARCINOGENESIS IN K14-HPV16 TRANSGENIC MICE. Paiva I, Gil da Costa RM, Ribeiro J, Sousa H, Bastos M, Rocha AF, Oliveira PA, Medeiros R. PLoS One. 2015 Jan 27;10(1):e0116868. https://doi.org/10.1371/journal.pone.0116868.

 

CYTOMEGALOVIRUS INFECTION IN PATIENTS WHO UNDERWENT ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PORTUGAL: A FIVE-YEAR RETROSPECTIVE REVIEW. Sousa H, Boutolleau D, Ribeiro J, Teixeira AL, Pinho-Vaz C, Campilho C, Branca R, Campos Jr A, Baldaque I, Medeiros R. Biol Blood Marrow Transplant. 2014 Dec;20(12):1958-67. https://doi.org/10.1016/j.bbmt.2014.08.010.

 

ROLE OF KEY TYMS POLYMORPHISMS ON METHOTREXATE THERAPEUTIC OUTCOME IN RHEUMATOID ARTHRITIS PORTUGUESE PATIENTS. Lima A, Seabra V, Bernardes M, Azevedo R, Sousa H, Medeiros R. PLoS One. 2014 Oct 3;9(10):e108165. https://doi.org/10.1371/journal.pone.0108165.

 

GENETIC POLYMORPHISMS IN LOW-DOSE METHOTREXATE TRANSPORTERS: THE CURRENT RELEVANCE AS METHOTREXATE THERAPEUTIC OUTCOME BIOMARKERS. Lima A, Sousa H, Monteiro J, Azevedo R, Medeiros R, Seabra V. Pharmacogenomics. 2014;15(12):1611-35. https://doi.org/10.2217/pgs.14.116.

 

SLC19A1, SLC46A1 AND SLCO1B1 POLYMORPHISMS AS PREDICTORS OF METHOTREXATE-RELATED TOXICITY IN PORTUGUESE RHEUMATOID ARTHRITIS PATIENTS. Lima A, Bernardes M, Azevedo R, Monteiro J, Sousa H, Medeiros R, Seabra V. Toxicol Sci. 2014 Nov;142(1):196-209. https://doi.org/10.1093/toxsci/kfu162.

 

PREDICTION OF METHOTREXATE CLINICAL RESPONSE IN PORTUGUESE RHEUMATOID ARTHRITIS PATIENTS: IMPLICATION OF MTHFR RS1801133 AND ATIC RS4673993 POLYMORPHISMS. Lima A, Monteiro J, Bernardes M, Sousa H, Azevedo R, Seabra V, Medeiros R. Biomed Res Int. 2014;2014:368681. https://doi.org/10.1155/2014/368681.

 

CHARACTERIZATION OF HUMAN PAPILLOMAVIRUS GENOTYPES AND HPV-16 PHYSICAL STATUS IN CERVICAL NEOPLASIAS OF WOMEN FROM NORTHERN PORTUGAL. Ribeiro J, Teixeira D, Marinho-Dias J, Monteiro P, Loureiro J, Baldaque I, Medeiros M, Sousa H. Int J Gynaecol Obstet. 2014 May;125(2):107-10. https://doi.org/10.1016/j.ijgo.2013.10.011.

 

GENETIC VARIABILITY IN KEY GENES IN PROSTAGLANDIN E2 PATHWAY (COX-2, HPGD, ABCC4 AND SLCO2A1) AND THEIR INVOLVEMENT IN COLORECTAL CANCER DEVELOPMENT. Pereira A, Queirós S, Sousa H, Galaghar A, Pimentel-Nunes P, Brandão C, Moreira-Dias L, Medeiros R, Dinis-Ribeiro M. PLoS One. 2014 Apr 2;9(4):e92000. https://doi.org/10.1371/journal.pone.0092000.

 

THE -1195G ALLELE INCREASES THE TRANSCRIPTIONAL ACTIVITY OF CYCLOOXYGENASE-2 GENE (COX-2) IN COLON CANCER CELL LINES. Pereira A, Sousa H, Silva J, Brandão C, Karstegl CE, Farrell PJ, Medeiros R, Dinis-Ribeiro M. Mol Carcinog. 2014 Feb;53 Suppl 1:E92-5. https://doi.org/10.1002/mc.22049.

 

MICRORNAS AS BIOMARKERS OF CERVICAL CANCER DEVELOPMENT: A LITERATURE REVIEW ON MIR-125B AND MIR-34A. Ribeiro J, Sousa H. Mol Biol Rep. 2014 Mar;41(3):1525-31. https://doi.org/10.1007/s11033-013-2998-0.

 

SLC19A1 80G ALLELE AS A BIOMARKER OF METHOTREXATE-RELATED GASTROINTESTINAL TOXICITY IN PORTUGUESE RHEUMATOID ARTHRITIS PATIENTS. Lima A, Bernardes M, Sousa H, Azevedo R, Costa L, Ventura F, Seabra V, Medeiros R. Pharmacogenomics. 2014 Apr;15(6):807-20. https://doi.org/10.2217/pgs.13.244.

 

TUMOR NECROSIS FACTOR ALPHA -308 G/A IS A RISK MARKER FOR THE PROGRESSION FROM HIGHGRADE LESIONS TO INVASIVE CERVICAL CANCER. Sousa H, Oliveira S, Santos A, Catarino R, Moutinho J, Medeiros R. Tumour Biol. 2014 Mar;35(3):2561-4. https://doi.org/10.1007/s13277-013-1337-3.

 

THE HIF1A FUNCTIONAL GENETIC POLYMORPHISM AT LOCUS +1772 ASSOCIATES WITH PROGRESSION TO METASTATIC PROSTATE CANCER AND REFRACTORINESS TO HORMONAL CASTRATION. Fraga A, Ribeiro R, Príncipe P, Lobato C, Pina F, Maurício J, Monteiro C, Sousa H, Calais da Silva F, Lopes C, Medeiros R. Eur J Cancer. 2014 Jan;50(2):359-65. https://doi.org/10.1016/j.ejca.2013.09.001.

 

CURRENT APPROACHES ON THYMIDYLATESYNTHASE POLYMORPHISMS AND ITS IMPORTANCE ON MOLECULAR EPIDEMIOLOGY AND PHARMACOGENETICS.Lima A, Azevedo R, Sousa H, Seabra V, Medeiros R. Pharmacogenomics. 2013 Aug;14(11):1337-51. doi: 10.2217/pgs.13.118.  https://doi.org/10.2217/PGS.13.118.

 

CHARACTERIZATION OF CYTOMEGALOVIRUS (CMV) AND EPSTEIN-BARR VIRUS (EBV) INFECTION IN CERVICAL LESIONS IN PORTUGAL. Marinho-Dias J, Ribeiro J, Monteiro P, Loureiro J, Baldaque I, Medeiros M, Sousa H. J Med Virol. 2013 Aug;85(8):1409-13. https://doi.org/10.1002/jmv.23596.

 

IL-1RN VNTR POLYMORPHISM AS A SUSCEPTIBILITY MARKER FOR NASOPHARYNGEAL CARCINOMA. Sousa H, Breda E, Santos AM, Catarino R, Pinto D, Canedo P, Machado JC, Medeiros R. Arch Oral Biol. 2013 Aug;58(8):1040-6. https://doi.org/10.1016/j.archoralbio.2013.02.004.

 

IS CHLAMYDIA TRACHOMATIS RELATED TO HUMAN PAPILLOMAVIRUS INFECTION IN YOUNG WOMEN OF SOUTHERN EUROPEAN POPULATION? A SELF-SAMPLING STUDY. Silva J, Cerqueira F, Ribeiro J, Sousa H, Osório T, Medeiros R. Arch Gynecol Obstet. 2013 Sep;288(3):627-33. https://doi.org/10.1007/s00404-013-2771-6.

 

CYTOMEGALOVIRUS INFECTION AND CERVICAL CANCER: FROM PAST DOUBTS TO ACTUAL QUESTIONS. Marinho-Dias J, Sousa H. Acta Médica Portuguesa. 2013 Mar-Apr;26(2):154-160.

 

IL-1RN VNTR POLYMORPHISM AND GENETIC SUSCEPTIBILITY TO CERVICAL CANCER IN PORTUGAL. Sousa H, Santos AM, Catarino R, Pinto D, Moutinho J, Canedo P, Machado JC, Medeiros R. Mol Biol Rep. 2012 Dec;39(12):10837-42. https://doi.org/10.1007/s11033-012-1979-z.

 

GENETIC POLYMORPHISM AND CERVICAL CANCER DEVELOPMENT: ATM G5557A AND P53BP1 C1236G. Oliveira S, Ribeiro J, Sousa H, Pinto D, Baldaque I, Medeiros R. Oncol Rep. 2012 Apr;27(4):1188-92. https://doi.org/10.3892/or.2011.1609.

66)  THE ROLE OF P73 G4C14-TO-A4T14 POLYMORPHISM IN THE SUSCEPTIBILITY TO CERVICAL CANCER. Craveiro R, Bravo I, Catarino R, Teixeira AL, Sousa H, Pereira D, Pereira H, Medeiros R. DNA Cell Biol. 2012 Feb;31(2):224-9. doi: 10.1089/dna.2011.1294. Epub 2011 Jun 28. https://doi.org/10.1089/DNA.2011.1294.

 

ONCOGENIC HPV TYPES INFECTION IN ADOLESCENTS AND UNIVERSITY WOMEN FROM NORTH PORTUGAL: FROM SELF-SAMPLING TO MOLECULAR CHARACTERIZATION. Silva J, Ribeiro J, Sousa H, Teixeira AL, Cerqueira F, Osório T, Baldaque I, Medeiros R. J Oncol. 2011; 2011:953469. https://doi.org/10.1155/2011/953469.

 

EPSTEIN-BARR VIRUS (EBV) IN HEALTHY INDIVIDUALS FROM PORTUGAL. Sousa H, Silva J, Azevedo L, Pinto‐Correia AL, Catarino R, Lopes C, Medeiros R. Acta Med Port. 2011 Sep-Oct;24(5):707-12. Epub 2011 Dec 29.

 

ROLE OF THE MDM2 SNP 309 POLYMORPHISM IN THE INITIATION AND EARLY AGE OF ONSET OF NASOPHARYNGEAL CARCINOMA. Sousa H, Pando M, Breda E, Catarino R, Medeiros R. Mol Carcinog. 2011 Feb;50(2):73-9. https://doi.org/10.1002/mc.20689.

 

GENETIC RISK MARKERS FOR NASOPHARYNGEAL CARCINOMA IN PORTUGAL: TUMOUR NECROSIS FACTOR ALPHA -308 G>A POLYMORPHISM. Sousa H, Breda E, Santos AM, Catarino R, Pinto D, Lopes C, Medeiros R. DNA Cell Biol. 2011 Feb;30(2):99-103. https://doi.org/10.1089/dna.2010.1086.

 

IS THERE A BIOLOGICAL PLAUSABILITY FOR P53 CODON 72 POLYMORPHISM INFLUENCE ON CERVICAL CANCER DEVELOPMENT? (REVIEW). Sousa H, Santos AM, Pinto D, Medeiros R. Acta Med Port. 2011 Jan-Feb;24(1):127-34. Epub 2011 Feb 28.

 

EPSTEIN-BARR VIRUS IS ASSOCIATED WITH GASTRIC CARCINOMA. THE QUESTION IS WHAT IS THE SIGNIFICANCE? Sousa H, Pinto-Correia AL, Medeiros R, Dinis-Ribeiro M. World J Gastroenterol. 2008 Jul 21;14(27):4347-51. https://doi.org/10.3748/WJG.14.4347

 

OVERALL SURVIVAL IN WOMEN WITH BREAST CANCER: THE INFLUENCE OF PEPSINOGEN C GENE POLYMORPHISM. Pinto-Correia AL, Pinto D, Pereira D, Rodrigues H, de Sousa JA, Sousa H, Sousa B, Sousa S, Lopes C, Medeiros R. DNA Cell Biol. 2008 Jun;27(6):333-6. https://doi.org/10.1089/dna.2007.0713.

 

THE P53 R72P POLYMORPHISM DOES NOT INFLUENCE CERVICAL CANCER DEVELOPMENT IN A PORTUGUESE POPULATION: A STUDY IN EXFOLIATED CERVICAL CELLS. Oliveira S, Sousa H, Santos AM, Pinto D, Pinto‐Correia AL, et al. J Med Virol. 2008 Mar;80(3):424-9. https://doi.org/10.1002/jmv.21103.

 

NASOPHARYNGEAL CARCINOMA STUDY: INTRODUCTION AND MULTIDISCIPLINARY PERSPECTIVE. Breda E, Catarino R, Coelho A, Sousa H, Medeiros R. Acta Med Port. 2008 May-Jun;21(3):273-84. Epub 2008 Jul 25.

 

IS THE P53 CODON 72 POLYMORPHISM A KEY BIOMARKER FOR CERVICAL CANCER DEVELOPMENT? A META-ANALYSIS REVIEW WITHIN EUROPEAN POPULATIONS. Sousa H, Santos AM, Pinto D, Medeiros R. Int J Mol Med. 2007 Nov;20(5):731-41. https://doi.org/10.3892/IJMM.20.5.731

 

THE INFLUENCE OF CHEMOKINE RECEPTOR CCR2 GENOTYPES IN THE ROUTE TO CERVICAL CARCINOGENESIS. Coelho A, Matos A, Catarino R, Pinto D, Sousa H,­ Pereira D, Medeiros R. Gynecol Obstet Invest. 2007;64(4):208-12. https://doi.org/10.1159/000106492

 

GASTRIC CANCER IN A CAUCASIAN POPULATION: THE ROLE OF PEPSINOGEN C GENETIC VARIANTS. Pinto-Correia AL, Sousa H, Fragoso M, Moreira-Dias L, Lopes C, Medeiros R, Dinis-Ribeiro M. World J Gastroenterol. 2006 Aug 21; 12(31): 5033-36. https://doi.org/10.3748/WJG.V12.I31.5033

 

THE -765G>C COX2 POLYMORPHISM MAY BE A SUSCEPTIBILITY MARKER FOR GASTRIC ADENOCARCINOMA IN PATIENTS WITH ATROPHY OR INTESTINAL METAPLASIA. Pereira C, Sousa H, Ferreira P, Fragoso M, Moreira-Dias L, et al. World J Gastroenterol. 2006 Sep 14; 12(34): 5473-8. https://doi.org/10.3748/WJG.V12.I34.5473

​

LINKAGE OF TP53 CODON 72 PRO/PRO GENOTYPE AS PREDICTIVE FACTOR FOR NASOPHARYNGEAL CARCINOMA DEVELOPMENT. Sousa H, Santos AM, Catarino R, Pinto D, Vasconcelos A, Breda E, Lopes C, Medeiros R.Eur J Cancer Prev. 2006 Aug; 15(4): 362-6. https://doi.org/10.1097/00008469-200608000-00010

 

ASSOCIATION OF THE A870G CYCLIN D1 GENE POLYMORPHISM WITH NASOPHARYNGEAL CARCINOMA.Catarino R, Breda E, Coelho V, Pinto D, Sousa H, Lopes C, Medeiros R. Head Neck. 2006 Jul; 28(7): 603-8. https://doi.org/10.1002/HED.20377.

 

LINKING TP53 CODON 72 AND P21 NT590 GENOTYPES TO THE DEVELOPMENT OF CERVICAL AND OVARIAN CANCER. Santos AM, Sousa H, Pinto D, Portela C, Pereira D, Catarino R, Duarte I, Lopes C, Medeiros R. Eur J Cancer.2006 May; 2(7):958-63. https://doi.org/10.1016/J.EJCA.2006.01.015.

 

TP53 AND P21 POLYMORPHISMS: RESPONSE TO CISPLATINUM/PACLITAXEL-BASED CHEMOTHERAPY IN OVARIAN CANCER. Santos AM, Sousa H, et al. Biochem Biophys Res Commun. 2006 Feb 3; 340(1): 256-62. 

https://doi.org/10.1016/J.BBRC.2005.11.176.

​

G-308A TNF-ALPHA POLYMORPHISM IS ASSOCIATED WITH AN INCREASED RISK OF INVASIVE CERVICAL CANCER. Duarte I, Santos A, Sousa H, Catarino R, Pinto D, Matos A, Pereira D, et al. Biochem Biophys Res Commun. 2005 Aug 26; 334(2): 588-92. https://doi.org/10.1016/J.BBRC.2005.06.137.

​

TP53 CODON 72 POLYMORPHISM AND RISK FOR CERVICAL CANCER IN PORTUGAL. Sousa H, Santos AM, Catarino R, Pinto D, Pereira D, Vasconcelos A, et al. Cancer Genet Cytogenet. 2005 Jun; 159(2): 143-7. https://doi.org/10.1016/J.CANCERGENCYTO.2004.10.005.

​

​